Concord Wealth Partners Pear Therapeutics, Inc. Transaction History

Concord Wealth Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$0.99 - $2.91 $990 - $2,910	1,000 Added 10.0%	11,000 $12,000
Q3 2022 Nov 10, 2022	BUY	$0.13 - $2.27 $390 - $6,810	3,000 Added 42.86%	10,000 $20,000
Q2 2022 Aug 04, 2022	BUY	$1.54 - $6.48 $10,780 - $45,360	7,000 New	7,000 $11,000
Q1 2022 Apr 20, 2022	SELL	$3.67 - $7.63 $3,670 - $7,630	-1,000 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$4.98 - $10.0 $4,980 - $10,000	1,000 New	1,000 $6,000

23M

Ticker PEAR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 138,768,992
Market Cap $1.39M
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.